Literature DB >> 11239448

Identification and characterization of a novel OCA-B isoform. implications for a role in B cell signaling pathways.

X Yu1, L Wang, Y Luo, R G Roeder.   

Abstract

OCA-B is a B lymphocyte-specific transcription coactivator that mediates tissue- and stage-restricted transcription of immunoglobulin genes. Earlier genetic studies revealed that OCA-B is essential for germinal center formation and production of secondary immunoglobulin isotypes. Biochemically purified OCA-B contains p35 and p34 isoforms, and a further analysis has now revealed that p35 is derived from a newly found isoform, p40. More importantly, it has been found that p35 is myristoylated in vivo and that this leads to dramatic changes (including localization to membrane compartments) in its properties. These results suggest that the p35 isoform of OCA-B has functions distinct from those of the nuclear p34 and that it might be a component of a signaling pathway that is required for late-stage B cell development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239448

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  15 in total

1.  Nuclear import of a lipid-modified transcription factor: mobilization of NFAT5 isoform a by osmotic stress.

Authors:  Birgit Eisenhaber; Michaela Sammer; Wai Heng Lua; Wolfgang Benetka; Lai Ling Liew; Weimiao Yu; Hwee Kuan Lee; Manfred Koranda; Frank Eisenhaber; Sharmila Adhikari
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

2.  Identification of transcription coactivator OCA-B-dependent genes involved in antigen-dependent B cell differentiation by cDNA array analyses.

Authors:  Unkyu Kim; Rachael Siegel; Xiaodi Ren; Cary S Gunther; Terry Gaasterland; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

3.  Proteomic analysis of fatty-acylated proteins in mammalian cells with chemical reporters reveals S-acylation of histone H3 variants.

Authors:  John P Wilson; Anuradha S Raghavan; Yu-Ying Yang; Guillaume Charron; Howard C Hang
Journal:  Mol Cell Proteomics       Date:  2010-11-14       Impact factor: 5.911

4.  Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.

Authors:  Christian Schmidt; Dongkyoon Kim; Gregory C Ippolito; Hassan R Naqvi; Loren Probst; Shawn Mathur; German Rosas-Acosta; Van G Wilson; Athenia L Oldham; Martin Poenie; Carol F Webb; Philip W Tucker
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

5.  BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment.

Authors:  Tatjana Samardzic; Dragan Marinkovic; Peter J Nielsen; Lars Nitschke; Thomas Wirth
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

6.  Regulation of BOB.1/OBF.1 stability by SIAH.

Authors:  J Boehm; Y He; A Greiner; L Staudt; T Wirth
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

7.  Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator.

Authors:  Helmut Laumen; Cornelia Brunner; Axel Greiner; Thomas Wirth
Journal:  Nucleic Acids Res       Date:  2004-03-05       Impact factor: 16.971

8.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

9.  A C-terminal acidic domain regulates degradation of the transcriptional coactivator Bob1.

Authors:  John M Lindner; Christina S F Wong; Andreas Möller; Peter J Nielsen
Journal:  Mol Cell Biol       Date:  2013-09-23       Impact factor: 4.272

10.  Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development.

Authors:  Alain Bordon; Nabil Bosco; Camille Du Roure; Boris Bartholdy; Hubertus Kohler; Gabriele Matthias; Antonius G Rolink; Patrick Matthias
Journal:  PLoS One       Date:  2008-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.